Sign In

Nico Straub

Partner Life Sciences/Biotech Venture Capital

Nico Straub is a seasoned professional in the fields of Venture Capital, Investments, Technology Inventions, and Patents. With a strong background in Technology Commercialization, Growth Strategy, and Start-ups, Nico has excelled in various roles within the industry.

Nico Straub's educational journey includes studying at Moll Gymnasium, obtaining a Master's in Finance with a focus on Corporate Finance and PE/VC from the prestigious London Business School, as well as pursuing a Diploma at the Karlsruher Institut für Technologie (KIT) and a Master's Degree at the University of Valencia.

Throughout his career, Nico has served in key positions such as Partner at Bioventure Management, Investor at DiaMonTech AG, Non-executive Board Member at Aphaia Pharma, and Board Observer at Aptarion biotech AG. His professional expertise spans across various domains, showcasing his proficiency and adeptness in the industry.

Highlights

Nov 22 · linkedin

Bioventure Management congratulates PROVIREX Genome Editing Therapies GmbH on winning a milestone award at the Göttingen Innovation Award 2023 in the category of companies with up to 20 employees

Jun 8 · linkedin

Wrapping up 4 days of sessions with leading experts, meetings with innovative new Biotechs, and with Big Pharma to discuss our outstanding portfolio companies Aphaia Pharma, Aptarion biotech AG, PROVIREX Genome Editing Therapies GmbH, and DiaMonTech AG at Bio International in Boston.

Related Questions

What are Nico Straub's main responsibilities at PROVIREX Genome Editing Therapies GmbH?
How did Nico Straub get involved with Bioventure Management GmbH?
What are some notable projects Nico Straub has worked on?
What is Nico Straub's educational background?
How has Nico Straub contributed to the field of genome editing therapies?
Nico Straub
Nico Straub, photo 1
Nico Straub, photo 2
Add to my network

Location

Hannover-Braunschweig-Göttingen-Wolfsburg Region